Furthermore, it registered a 11 percent hike in net sales of final products, up to RON 18.63 million (€4.37 mln). The company's indebtedness degree is below 5 percent, which and insure growth potential, a Biofarm release writes. The producer is listed on Bucharest Stock Exchange (BVB)'s electronic Rasdaq market.
